This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Choi, J.H. et al. Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPARγ by Cdk5. Nature 466, 451–456 (2010).
Lehrke, M. & Lazar, M.A. The many faces of PPARγ. Cell 123, 993–999 (2005).
Gronemeyer, H., Gustafsson, J.A. & Laudet, V. Principles for modulation of the nuclear receptor superfamily. Nat. Rev. Drug Discov. 3, 950–964 (2004).
Olefsky, J.M. and Glass, C.K. Macrophage, inflammation and insulin resistance. Ann. Rev. Physiol. 72, 219–246 (2010).
Vernochet, C. et al. C/EBPα and the corepressors CtBP1 and CtBP2 regulate repression of select visceral white adipose genes during induction of the brown phenotype in white adipocytes by peroxisome proliferator-activated receptor γ agonists. Mol. Cell Biol. 29, 4714–4728 (2010).
Ethics declarations
Competing interests
M.A.L. has served as a consultant to GlaxoSmithKline, Eli Lilly and Dr. Reddy's Laboratories.
Rights and permissions
About this article
Cite this article
Antidiabetes wars: a new hope. Nat Med 16, 972–973 (2010). https://doi.org/10.1038/nm0910-972
Issue Date:
DOI: https://doi.org/10.1038/nm0910-972